Announced Wed, 8 Apr · 16:05 IST

Please find enclosed herewith intimation under Regulation 74(5) of SEBI (DP) Regulations, 2015 for quarter ended March, 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.6%1-day move

₹91.00

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+3.6+5.5+17.6+29.7+36.3+28.0+37.6+39.3+40.7+34.1

Up moveDown movePending

AI summary

Godavari Drugs Ltd has filed a compliance certificate confirming proper handling of securities dematerialization for the quarter ending March 31, 2026. The certificate was issued by CIL Securities Limited, the company's Registrar and Share Transfer Agent. The filing confirms that physical share certificates received for dematerialization were properly mutilated and cancelled after verification. The depositories have been substituted as registered owners in the company's Register of Members within the stipulated time period. This is a routine quarterly regulatory filing as required under SEBI regulations.

Likely market impact

This is a standard regulatory compliance filing with no material impact on shareholders or stock price. It simply confirms the company followed proper procedures for processing dematerialization requests during the quarter.